{"id":410381,"date":"2025-11-23T00:30:00","date_gmt":"2025-11-22T23:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/cbt-i-as-first-choice-pharmacotherapy-as-secondary-intervention\/"},"modified":"2025-11-22T23:48:43","modified_gmt":"2025-11-22T22:48:43","slug":"cbt-i-as-first-choice-pharmacotherapy-as-secondary-intervention","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/cbt-i-as-first-choice-pharmacotherapy-as-secondary-intervention\/","title":{"rendered":"CBT-i as first choice &#8211; pharmacotherapy as secondary intervention"},"content":{"rendered":"\n<p><strong>Sleep disorders are often associated with pronounced daytime sleepiness, difficulty concentrating and increased feelings of stress. Diagnosis is generally based on the clinical history; if necessary, an actigraphy or polysomnigraphy can also be informative. Cognitive behavioral therapy (CBT-i) is recommended as a first-line treatment for chronic insomnia in both the current European guidelines and the German guideline updated in 2025. Digital tools can support treatment. If medication is used, there are a few things to bear in mind.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fcbt-i-as-first-choice-pharmacotherapy-as-secondary-intervention%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Sleep disorders are often associated with pronounced daytime sleepiness, difficulty concentrating and increased feelings of stress. Diagnosis is generally based on the clinical history; if necessary, an actigraphy or polysomnigraphy&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fcbt-i-as-first-choice-pharmacotherapy-as-secondary-intervention%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":410388,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Chronic insomnia in adults: Guideline recommendations","footnotes":""},"category":[11513,11363,11427,11442,11466,11548,11503],"tags":[53132,34005,85615,85619,12225,44007,85608,34001,85624,85607,11780,12550,13545,85610,85612,85617,44225,85622],"powerkit_post_featured":[],"class_list":["post-410381","post","type-post","status-publish","format-standard","has-post-thumbnail","category-congress-reports","category-neurology","category-orl-en","category-pharmacology-and-toxicology","category-psychiatry-and-psychotherapy","category-rx-en","category-studies","tag-agomelatine","tag-amitriptyline","tag-cbt-i","tag-diazepam","tag-guideline-en","tag-intervention-en","tag-melatonin","tag-mirtazapine","tag-orexin-receptor-antagonists-daridorexant","tag-oxazepam","tag-pharmacotherapy","tag-phytotherapy","tag-trazodone-en","tag-trimipramine","tag-z-substances","tag-zaleplon","tag-zolpidem-en","tag-zoplicon","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-22 22:13:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":410394,"slug":"la-tcc-i-en-premiere-intention-la-pharmacotherapie-comme-intervention-de-second-ordre","post_title":"La TCC-i en premi\u00e8re intention - la pharmacoth\u00e9rapie comme intervention de second ordre","href":"https:\/\/medizinonline.com\/fr\/la-tcc-i-en-premiere-intention-la-pharmacotherapie-comme-intervention-de-second-ordre\/"},"it_IT":{"locale":"it_IT","id":410428,"slug":"cbt-i-come-prima-scelta-farmacoterapia-come-intervento-secondario","post_title":"CBT-i come prima scelta - farmacoterapia come intervento secondario","href":"https:\/\/medizinonline.com\/it\/cbt-i-come-prima-scelta-farmacoterapia-come-intervento-secondario\/"},"pt_PT":{"locale":"pt_PT","id":410383,"slug":"a-tcc-i-como-primeira-escolha-a-farmacoterapia-como-intervencao-secundaria","post_title":"A TCC-i como primeira escolha - a farmacoterapia como interven\u00e7\u00e3o secund\u00e1ria","href":"https:\/\/medizinonline.com\/pt-pt\/a-tcc-i-como-primeira-escolha-a-farmacoterapia-como-intervencao-secundaria\/"},"es_ES":{"locale":"es_ES","id":410385,"slug":"tcc-i-como-primera-opcion-farmacoterapia-como-intervencion-secundaria","post_title":"TCC-i como primera opci\u00f3n - farmacoterapia como intervenci\u00f3n secundaria","href":"https:\/\/medizinonline.com\/es\/tcc-i-como-primera-opcion-farmacoterapia-como-intervencion-secundaria\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/410381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=410381"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/410381\/revisions"}],"predecessor-version":[{"id":410390,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/410381\/revisions\/410390"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/410388"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=410381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=410381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=410381"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=410381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}